non-small cell lung cancer (NSCLC), colorectal cancer (CRC) , gastrointestinal stromal tumor (GIST)
Conditions
Interventions
Gold Standard:Comparison methods :(1) comparison of similar kits
(2) Sequencing method
gene 
Detection 
Kit 
terminal 
termination 
Sponsors
Shanghai Chest Hospital
Eligibility
Sex/Gender
All
Age
No minimum to 100 Years
Inclusion criteria
Inclusion criteria: "In this clinical trial, patients with pathologically diagnosed non-small cell lung cancer (NSCLC) or colorectal cancer (CRC) or gastrointestinal stromal tumor (GIST) were selected as the included patients. Meanwhile, some benign tumors were selected as interference samples for detection.The patient's gender and age are not limited. Inclusion criteria for the case group (in line with 1 and 4 or in line with 2 and 4 or in line with 3 and 4): 1. Patients with pathologically diagnosed non-small cell lung cancer (NSCLC); 2. Patients with pathological diagnosis of colorectal cancer (CRC); 3. Patients diagnosed by pathology with gastrointestinal stromal tumor (GIST); 4. The proportion of tumor cells evaluated by pathology is not less than 20%. Inclusion criteria for the control group (in line with 5): 5. Benign tumor or inflammatory tissue after pathological diagnosis.
Exclusion criteria
Exclusion criteria: 1. Patients not conforming to the pathological diagnosis of non-small cell lung cancer (NSCLC) or colorectal cancer (CRC) or gastrointestinal stromal tumor (GIST); 2. The proportion of pathologically assessed tumor cells was less than 20%; 3. The preservation time of samples after collection is more than 24 months when the samples are enrolled; 4. Tissue samples cannot meet the detection requirements (such as insufficient wax samples, wax block loss, etc.); 5. Repeated sampling for the same case; 6. Out of number of cases (competitive entry); 7. Sample information is incomplete and non-standard, such as lack of traceability key information, unclear diagnostic information, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lung and gastrointestinal tumor genes; | — |
Countries
China
Contacts
Public ContactTang Yuan
West China Hospital, Sichuan University
Outcome results
None listed